Cutler Group LP Kempharm, Inc Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$4.12 - $5.62 $5,768 - $7,868	-1,400 Reduced 67.34%	679 $3,000
Q3 2022 Oct 25, 2022	SELL	$4.5 - $6.85 $12,451 - $18,953	-2,767 Reduced 57.1%	2,079 $12,000
Q1 2022 Apr 14, 2022	SELL	$5.0 - $9.26 $21,315 - $39,475	-4,263 Reduced 46.8%	4,846 $24,000
Q4 2021 Jan 18, 2022	BUY	$7.6 - $10.26 $36,472 - $49,237	4,799 Added 111.35%	9,109 $79,000
Q2 2021 Jul 19, 2021	SELL	$8.52 - $15.47 $74,251 - $134,821	-8,715 Reduced 66.91%	4,310 $55,000
Q1 2021 Apr 26, 2021	BUY	$5.6 - $13.47 $72,940 - $175,446	13,025 New	13,025 $119,000

116

26M

591K

242K

Ticker KMPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,493,600
Market Cap $170M
Description
KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.